Recent studies have also identified potentialbiomarkers for otherneurodegenerative diseases, such as amyotrophic lateral sclerosis(ALS), Huntington’s disease, and multiple sclerosis163−165 These biomarkers include glial fibrillary acidic protein and myelinessential protein, which are indicative of neuronal damage, inflammation,and demyelination, respectively166,167. This evidence concerns the gene GFAP and amyotrophic lateral sclerosis.